http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101952270-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64fab711e94aa910dfb7511bb1bf834e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04
filingDate 2009-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b893764d0542c7e29fcf2fa023f2c34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e155d192dac1cad21e92098762dbf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_128cd4d122a6e96c4e5a04965d8f27e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ae89276e7376ed9e3bec7bf1b8b6c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_411343f549ce574170d98c9b9d0ad210
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fde2a138aa7d3fd8b12bcf4d8552a03
publicationDate 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101952270-B
titleOfInvention Process for preparing nebivolol
abstract The present invention relates to a process for reducing a compound of formula (I) wherein X is halogen, a hydroxy group, an alkylsulfoniloxy group or an arylsulfonyloxy group; to give a compound of formula (II) as a diastereoisomerically pure compound of RS/SR configuration characterized in that said reduction is carried out by the use of (+)-B- chlorodiisopinocampheylborane or (-)-B- chlorodiisopinocampheylborane. The compounds of formula (II) are useful as intermediates for the preparation of Nebivolol.
priorityDate 2008-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1803715-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413543389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11658439

Total number of triples: 22.